Hemodialysis (HD) is one of the renal replacement therapy ways to treat acute or chronic renal failure patients. Presently, there are more than 2 million end-stage renal disease (ESRD) patients all over the world who choose the dialysis therapy, and about 90% of them receive hemodialysis. Because of the high hemodialysis expenses, the dialysis patients mainly concentrate in developed countries. ESRD patients on dialysis account for 10%-20% in developing countries, which is far lower than the 80% in developed countries. The population of dialysis patients is relatively small but fast-growing. In recent years, the annual growth rate of dialysis patients reached over 10% in China, India and Brazil, which was much higher compared to 3%-5% in developed countries.
With the increasing dialysis patients, the number of the global dialysis centers is correspondingly growing, of which the growth rate is consistent with that of dialysis patients. In 2015, the global dialysis centers were estimated to reach 38,000. On average, every dialysis center provided services to 70-80 patients. Based on the relatively high dialysis rate and the slow increase of dialysis patients, it is predicted that the new hemodialysis centers will be constructed in emerging markets of Asia-Pacific regions especially China. Presently, there are a large number of unsatisfied requirements, which will be the significant points of the future dialysis market.
Up to the end of 2015, China had the population of more than 1.37 billion, and ESRD patients surpassed 2 million. Unable to afford it, only a small proportion of end-stage renal disease patients can receive the dialysis therapy. There were 300,000 dialysis patients in China by the end of 2015. The overall dialysis treatment rate was estimated to reach 14%-15% in China, which was lower than the average global level of 38%-40%. It was far lower than the above 90% treatment rate in developed countries. Therefore, there were large development potentials in Chinese dialysis market.